Bluejay Diagnostics Inc stock is traded at $2.68, with a volume of 25,958. It is up +7.63% in the last 24 hours and down -18.68% over the past month. Bluejay Diagnostics Inc is a medical diagnostics company focused on improving patient outcomes using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression. Bluejay's first product candidate, an IL-6 Test for sepsis, is designed to provide accurate, reliable results in approximately 20 minutes from sample-to-result to help medical professionals make earlier and quicker triage/treatment decisions.
Previous Close:
$2.49
Open:
$2.52
24h Volume:
25,958
Relative Volume:
0.30
Market Cap:
$2.99M
Revenue:
$249.00K
Net Income/Loss:
-$6.90M
P/E Ratio:
-
EPS:
-$14.02
Net Cash Flow:
-$6.65M
1W Performance:
+21.27%
1M Performance:
-18.68%
6M Performance:
-61.05%
1Y Performance:
-89.33%
1-Day Range:
$2.43$2.68
1-Week Range:
$2.10$2.68
52-Week Range:
$1.84$28.00
Bluejay Diagnostics Inc Stock (BJDX) Company Profile
Name
Bluejay Diagnostics IncSector
HealthcareIndustry
Medical DevicesPhone
(978) 631-0152Address
360 MASSACHUSETTS AVENUE, SUITE 203, ACTON, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS